1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Impact of Cernitin™ on induced chronic prostatitis in animal model for understanding management of lower urinary tract symptoms
(
- Contribution to journal › Article
- 2019
-
Mark
The effects of Cernitin® on inflammatory parameters and benign prostatic hyperplasia : An in vitro study
(
- Contribution to journal › Article
- 2013
-
Mark
Cyclin A1 modulates the expression of vascular endothelial growth factor and promotes hormone-dependent growth and angiogenesis of breast cancer.
(
- Contribution to journal › Article
- 2011
-
Mark
Serotonin activates MAP kinase and PI3K/Akt signaling pathways in prostate cancer cell lines.
(
- Contribution to journal › Article
- 2009
-
Mark
CYCLIN A1 MEDIATES DRUG-RESISTANT METASTATIC SPREAD OF PCA CELLS IN XENOGRAFTS IN VIVO
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
The effect of a novel botanical agent TBS-101 on invasive prostate cancer in animal models.
(
- Contribution to journal › Article
- 2008
-
Mark
Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
(
- Contribution to journal › Article
-
Mark
Intermittent DHT administration enhances effect of docetaxel in a xenograft model by modulation of ER beta, AR and NEK2
2008) 23rd Annual Congress of the European Association of Urology, 2008 In European Urology Supplements 7(3). p.278-278(
- Contribution to journal › Published meeting abstract
-
Mark
Multiple Cellular Mechanisms In Prostate Cancer Invasion And Metastasis
(
- Contribution to journal › Published meeting abstract
-
Mark
Hormonal regulation of beta(2)-adrenergic receptor level in prostate cancer
(
- Contribution to journal › Article